Search research articles
Contact Us
Filters
Showing results (541-550 of 625) with videos related to
Page
of 63
Sort By:
Annals of Surgery
|
February 1, 2003
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial
Joseph S Solomkin, Albert E Yellin, Ori D Rotstein, et al.
The Israel Medical Association Journal : IMAJ
|
July 13, 2006
Lung transplantation in patients with cystic fibrosis: the Israeli experience
Dario Prais, Yael Raviv, David Shitrit, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 30, 2009
Selective removal of stratum corneum by microdermabrasion to increase skin permeability
Harvinder S Gill, Samantha N Andrews, Senthilkumar K Sakthivel, et al.
Annals of Surgery
|
July 21, 2000
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections
S M Cohn, P A Lipsett, T G Buchman, et al.
Leukemia
|
January 17, 2014
Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
J R Berenson, J D Hilger, O Yellin, et al.
Journal of Palliative Medicine
|
May 20, 2026
Impact of Patient-Oncologist Language Concordance on the Quality of End-of-Life Care
Katherine Yoh, Lielle R Yellin, Joel Agarwal, et al.
Mbio
|
March 5, 2025
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming
Mark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
British Journal of Haematology
|
November 16, 2012
Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
James R Berenson, Ori Yellin, Alberto Bessudo, et al.
Surgery
|
October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status report
H Buchwald, R B Moore, J P Matts, et al.
Page
of 63
Search research articles
Search
Showing results (541-550 of 625) with videos related to
Sort By:
Page
of 63
Annals of Surgery
|
February 1, 2003
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial
Joseph S Solomkin, Albert E Yellin, Ori D Rotstein, et al.
The Israel Medical Association Journal : IMAJ
|
July 13, 2006
Lung transplantation in patients with cystic fibrosis: the Israeli experience
Dario Prais, Yael Raviv, David Shitrit, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 30, 2009
Selective removal of stratum corneum by microdermabrasion to increase skin permeability
Harvinder S Gill, Samantha N Andrews, Senthilkumar K Sakthivel, et al.
Annals of Surgery
|
July 21, 2000
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections
S M Cohn, P A Lipsett, T G Buchman, et al.
Leukemia
|
January 17, 2014
Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
J R Berenson, J D Hilger, O Yellin, et al.
Journal of Palliative Medicine
|
May 20, 2026
Impact of Patient-Oncologist Language Concordance on the Quality of End-of-Life Care
Katherine Yoh, Lielle R Yellin, Joel Agarwal, et al.
Mbio
|
March 5, 2025
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming
Mark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
British Journal of Haematology
|
November 16, 2012
Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
James R Berenson, Ori Yellin, Alberto Bessudo, et al.
Surgery
|
October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status report
H Buchwald, R B Moore, J P Matts, et al.
Page
of 63